CinnaGen Co.
Industry
- Medical Devices
- Diagnostic Imaging Equipment & Supplies
- Molecular Imaging
- Diagnostic Imaging Equipment & Supplies
- Biotechnology
- Contract Manufacturing Organization
Latest on CinnaGen Co.
Aurobindo Pharma is conducting Phase III trials for a biosimilar to multi-billion immunology product Xolair (omalizumab), originally developed and sold by Roche unit Genentech and Novartis , CEO
Aurobindo Pharma Limited is conducting Phase III trials for a biosimilar to multi-billion immunology product Xolair (omalizumab), originally developed and sold by Roche Holding AG unit Genentech,
The Australian regulator, the Therapeutic Goods Administration, has granted a provisional approval to GlaxoSmithKline plc / Vir Biotechnology, Inc. ’s monoclonal antibody, Xevudy (sotrovimab), for th
Iranian biotech CinnaGen has unveiled positive results from the firm’s clinical studies trialing its ReciGen (interferon beta-1a) multiple-sclerosis as a treatment option to reduce COVID-19 symptoms